Table 2.
Outcomes, Tolerability, and Safety
| Group HS (n = 28) | Group S (n = 27) | P value | |
|---|---|---|---|
| Ventilator free days | 4.7 ± 3.3 | 2.4 ± 2.6 | 0.007* |
| Number of doses of nebulization withheld/patient | 5.8 ± 2.2 | 4.8 ± 1.4 | 0.064 |
| Blood transfusion | 9 | 7 | 0.612 |
| APTT Max (s) | 39.5 ± 2.5 | 39.1 ± 1.0 | 0.407 |
| APTT elevation (s) | 0.9 ± 1.8 | 0.2 ± 0.9 | 0.053 |
| APTT Max ≥ 40.0 (s) | 13 | 9 | 0.322 |
| Double APTT | 0 | 0 | -- |
| HIT | 0 | 0 | -- |
| Death | 2 | 3 | 0.669 |
Values are presented as mean ± SD or a frequency as appropriate. Group HS: heparin and salbutamol group, Group S: salbutamol only group. APTT: activated partial thromboplastin time, HIT: heparin-induced thrombocytopenia.
*
Statistically significant with P < 0.05.